argenx
About:
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Website: https://www.argenx.com/
Twitter/X: argenxglobal
Top Investors: OrbiMed, Seventure Partners, Aquila Capital, EQT Life Sciences, Dafna Capital Management
Description:
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Total Funding Amount:
$3.75B
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)argen-x.com
Founders:
Tim Van Hauwermeiren
Number of Employees:
501-1000
Last Funding Date:
2023-07-19
IPO Status:
Public
© 2025 bioDAO.ai